Patents by Inventor Shmuel Ben Eliahu

Shmuel Ben Eliahu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082595
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: January 1, 2023
    Publication date: March 13, 2025
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker
  • Publication number: 20240315997
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder. e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: October 26, 2023
    Publication date: September 26, 2024
    Applicant: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • Patent number: 11844754
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: December 19, 2023
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • Publication number: 20230157985
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 25, 2023
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein